Are AI-driven insights the future of precision medicine, reshaping clinical data analysis as we know it? The inherent complexity of cancer and the particular requirements for unravelling new biomarkers and predicting treatment response warrants a novel...
We are very happy to share our latest review paper! The power of personalized immunotherapy is becoming more and more apparent. The data presented at the AACR Annual meeting and the Neoantigen Summit this spring is exciting and showcases the momentum...
myNEO Therapeutics launches myNEO Tx academy on LinkedIn as we believe in the power of education! Each month we will touch upon a different topic to inform you and get you as excited as we are about neoantigen discovery and cancer immunotherapy! Follow-us on LinkedIn...
myNEO Therapeutics’ CEO, Cedric Bogaert, recently won a spot on the Forbes30under30 List 2023! We are very honored and excited about this achievement. Here is what he had to say about earning the spot. “What started out 6 years ago as experimenting with some...
Lymfklierkanker Vereniging Vlaanderen (LVV) is organizing a webinar on January 28th where Lien Lybaert will explain in understandable language to cancer patients, their loved ones & sympathizers what has fascinated her for 10 years now: IMMUNOTHERAPY. What is the...
myNEO Therapeutics aims this year to double the team in size due to our growing project portfolio with multiple different partners. The neoantigen discovery team has been joined by Gitta Boons and Lies van Olmen earlier this year and we are currently recruiting at...
